13F HOLDINGS REPORT
5AM Venture Management, LLC
Quarter ended Q4 2023 · Filed November 14, 2023 · Accession 0001104659-23-118105
Total Value
$347.5M
Positions
26
Other Managers
0
Confidential Omitted
No
Holdings (26)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | ENLIVEN THERAPEUTICS INC | ELVN | 5,160,975 | $70.5M | 20.29% |
| 2 | ENTRADA THERAPEUTICS INC | TRDA | 4,408,379 | $69.7M | 20.04% |
| 3 | DISC MEDICINE INC | IRON | 438,442 | $20.6M | 5.93% |
| 4 | DIANTHUS THERAPEUTICS INC | DNTH | 1,472,264 | $20.1M | 5.79% |
| 5 | MOONLAKE IMMUNOTHERAPEUTICS | MLTX | 313,210 | $17.9M | 5.14% |
| 6 | CRINETICS PHARMACEUTICALS IN | CRNX | 462,286 | $13.7M | 3.96% |
| 7 | VOR BIOPHARMA INC | VOR | 6,361,723 | $13.5M | 3.88% |
| 8 | PHARVARIS N V | PHVS | 587,600 | $12.3M | 3.53% |
| 9 | RALLYBIO CORP | RLYB | 3,630,724 | $12.2M | 3.52% |
| 10 | ZENTALIS PHARMACEUTICALS INC | ZNTL | 490,000 | $9.8M | 2.83% |
| 11 | SCPHARMACEUTICALS INC | 810648105 | 1,200,647 | $8.5M | 2.46% |
| 12 | CELLDEX THERAPEUTICS INC NEW | CLDX | 310,270 | $8.5M | 2.46% |
| 13 | MIRATI THERAPEUTICS INC | 60468T105 | 192,500 | $8.4M | 2.41% |
| 14 | COGENT BIOSCIENCES INC | COGT | 790,440 | $7.7M | 2.22% |
| 15 | VIKING THERAPEUTICS INC | VKTX | 585,000 | $6.5M | 1.86% |
| 16 | ANAPTYSBIO INC | ANABV | 357,733 | $6.4M | 1.85% |
| 17 | VIRIDIAN THERAPEUTICS INC | VRDN | 410,000 | $6.3M | 1.81% |
| 18 | ARVINAS INC | ARVN | 320,000 | $6.3M | 1.81% |
| 19 | TYRA BIOSCIENCES INC | TYRA | 411,450 | $5.7M | 1.63% |
| 20 | SPRUCE BIOSCIENCES INC | SPRB | 2,364,000 | $5.3M | 1.54% |
| 21 | HOMOLOGY MEDICINES INC | 438083107 | 4,535,919 | $5.3M | 1.53% |
| 22 | AVIDITY BIOSCIENCES INC | 05370A108 | 665,555 | $4.2M | 1.22% |
| 23 | GH RESEARCH PLC | GHRS | 404,404 | $4.1M | 1.17% |
| 24 | MERSANA THERAPEUTICS INC | 59045L106 | 1,305,000 | $1.7M | 0.48% |
| 25 | IMPEL PHARMACEUTICALS INC | 45258K109 | 2,884,791 | $1.2M | 0.36% |
| 26 | CIDARA THERAPEUTICS INC | 171757107 | 1,134,511 | $1.1M | 0.31% |